Back Stocks profile

Stock analysis tool for investors

Sun Pharmaceutical Industries Ltd.

NSE: SUNPHARMA | BSE:524715

₹1493.80 8.05 (0.54%) 1D

Pharmaceuticals & Biotechnology

View detailed Technical chart

Open an Account with Bigul in 5 minutes

Performance

Today’s low

1488.60

Today’s High

1503.70

52W low

922.40

52W High

1638.80

Open Price

1490.00

Prev. Close

1125.85

Volume

124227.00

Value

185570292.60

Fundamentals

Market Cap Cr

358412.70

Price to Earnings

40.20

Price to Book Value

6.00

Dividend Yield

0.80

PE to Growth

0.40

Op Revenue TTM Cr

47444.62

Net Profit TTM Cr

8906.27

Cash From Operating Activity Cr

4959.33

Return on Equity %

15.13

EMA & SMA

Bullish Moving Averages

5

Bearish Moving Averages

11

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

24 Apr, 2024

73.8

Week

68.6

Month

64.4

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

1489.37

PIVOT

First Resistance

1499.38

Second Resistance

1513.02

Third Resistance

1523.03

First Support

1475.73

Second Support

1465.72

Third Support

1452.08

Relative Strength Index

32.73

Money Flow Index

11.96

MACD

-16.4

MACD Signal

-2.1

Average True Range

34.68

Average Directional Index

29.55

Rate of Change (21)

-4.1

Rate of Change (125)

30.08

Commodity Channel Index

-140.1

Williams %R

-95

BETA

1 Month

1.18

3 Month

0.96

1 Year

0.33

3 Year

0.07

PRICE CHANGE ANALYSIS

-2.85%

1 Week

Low

High

1477.7

1562.45

-7.15%

1 Month

Low

High

1477.7

1638.85

8.08%

3 Months

Low

High

1348.5

1638.85

33.08%

6 Months

Low

High

1068.35

1638.85

52.56%

1 Year

Low

High

922.45

1638.85

24 Apr 2024

Sun Pharma - Specialty' Way Of Driving Growth Prospects: Motilal Oswal

Values Sun Pharma at 30 times 12 months forward earnings to arrive at a target price of Rs 1,870.
18 Apr 2024

Sun Pharma-FDA: Regulatory Concerns At Dadra facility Can Dent Sentiment, Say Analysts

Analysts say that the FDA action at the Dadra unit can push Sun Pharma's stock into a price-wise corrective phase.
Bigul
15 Apr 2024

SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Compliance Certificate Under Regulation 7 (3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Intimation regarding Compliance Certificate under Regulation 7 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
15 Apr 2024

Another regulatory blow for Sun Pharma after Dadra unit tagged 'OAI' by US FDA, stock down

The official action indicated classification for the Dadra unit by FDA follows similar trouble at Sun Pharma's Halol and Mohali facilities recently, which hit generic sales
12 Apr 2024

Sun Pharma At Over Three-Week Low After FDA's Action On Dadra Plant

The stock fell as much as 4.2% during the day on the NSE to the lowest since March 20.
See all News

FAQs

The latest market price of Sun Pharmaceutical Industries Ltd. on NSE was Rs. 1493.80 as of today.

The opening share price of Sun Pharmaceutical Industries Ltd. was Rs. 1490.00 as of today.

The 52-week high share price of Sun Pharmaceutical Industries Ltd. was Rs. 1638.80.

The 52 week low share price of Sun Pharmaceutical Industries Ltd. was Rs. 922.40.

Sun Pharmaceutical Industries Ltd. has a market cap of Rs. 358412.70 crore as of today. Please refer to the Fundamentals section for further details.

The PE ratio of Sun Pharmaceutical Industries Ltd. is 0.40. Please refer to the Fundamentals section for further details.

The operating revenue for Sun Pharmaceutical Industries Ltd. in the last FY was Rs.  47444.62 crore. Please refer to the Financials section for further details.

The Net Profit for Sun Pharmaceutical Industries Ltd. in the last FY was Rs. 8906.27 crore. Please refer to the Financials section for further details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

The latest dividend declared by Sun Pharmaceutical Industries Ltd. was on 2024-02-09 for Rs. 8.5 per share. According to today’s share price, the dividend yield of Sun Pharmaceutical Industries Ltd. stands at 0.80. Please refer to the Corporate Actions section for further details.

The latest bonus issue declared by Sun Pharmaceutical Industries Ltd. was as of 2013-07-29. The bonus ratio declared in this issue was 1:1. Please refer to the Corporate Actions section for further details.

The latest split issue declared by Sun Pharmaceutical Industries Ltd. was as of 2003-01-13. The split ratio declared in this issue was 10:5. Please refer to the Corporate Actions section for further details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Sun Pharmaceutical Industries Ltd..

Open Account

Let's Open Free Demat Account

Close

Let's Open Free Demat Account